These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11906096)

  • 1. In vitro and in vivo evaluation of aminopeptidase inhibitors as antimicrosporidial therapies.
    Millership JJ; Didier ES; Okhuysen PC; Maddry JA; Kwong CD; Chen X; Snowden KF
    J Eukaryot Microbiol; 2001; Suppl():95S-98S. PubMed ID: 11906096
    [No Abstract]   [Full Text] [Related]  

  • 2. TNP-470 is an effective antimicrosporidial agent.
    Coyle C; Kent M; Tanowitz HB; Wittner M; Weiss LM
    J Infect Dis; 1998 Feb; 177(2):515-8. PubMed ID: 9466552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microsporidian methionine aminopeptidase type 2.
    Weiss LM; Costa SF; Zhang H
    J Eukaryot Microbiol; 2001; Suppl():88S-90S. PubMed ID: 11906093
    [No Abstract]   [Full Text] [Related]  

  • 4. Homology modeling and calculation of the cobalt cluster charges of the Encephazlitozoon cuniculi methionine aminopeptidase, a potential target for drug design.
    Bontems F; le Floch P; Duffieux F; Biderre C; Peyret P; Lallemand JY
    Biophys Chem; 2003 Aug; 105(1):29-43. PubMed ID: 12932577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. QSAR of the inhibition of angiogenesis by TNP-470 and ovalicin analogues: another example of an allosteric interaction.
    Mekapati SB; Hansch C
    Bioorg Med Chem; 2001 Dec; 9(12):3225-30. PubMed ID: 11711298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrosporidial activities of fumagillin, TNP-470, ovalicin, and ovalicin derivatives in vitro and in vivo.
    Didier PJ; Phillips JN; Kuebler DJ; Nasr M; Brindley PJ; Stovall ME; Bowers LC; Didier ES
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2146-55. PubMed ID: 16723577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure of a microsporidian methionine aminopeptidase type 2 complexed with fumagillin and TNP-470.
    Alvarado JJ; Nemkal A; Sauder JM; Russell M; Akiyoshi DE; Shi W; Almo SC; Weiss LM
    Mol Biochem Parasitol; 2009 Dec; 168(2):158-67. PubMed ID: 19660503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methionine aminopeptidase (type 2) is the common target for angiogenesis inhibitors AGM-1470 and ovalicin.
    Griffith EC; Su Z; Turk BE; Chen S; Chang YH; Wu Z; Biemann K; Liu JO
    Chem Biol; 1997 Jun; 4(6):461-71. PubMed ID: 9224570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2.
    Sin N; Meng L; Wang MQ; Wen JJ; Bornmann WG; Crews CM
    Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6099-103. PubMed ID: 9177176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiogenesis inhibitors specific for methionine aminopeptidase 2 as drugs for malaria and leishmaniasis.
    Zhang P; Nicholson DE; Bujnicki JM; Su X; Brendle JJ; Ferdig M; Kyle DE; Milhous WK; Chiang PK
    J Biomed Sci; 2002; 9(1):34-40. PubMed ID: 11810023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of albendazole, fumagillin, and TNP-470 on microsporidial replication in vitro.
    Didier ES
    Antimicrob Agents Chemother; 1997 Jul; 41(7):1541-6. PubMed ID: 9210681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methionine AminoPeptidase Type-2 Inhibitors Targeting Angiogenesis.
    Ehlers T; Furness S; Robinson TP; Zhong HA; Goldsmith D; Aribser J; Bowen JP
    Curr Top Med Chem; 2016; 16(13):1478-88. PubMed ID: 26369821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility of Encephalitozoon cuniculi to several drugs in vitro.
    Franssen FF; Lumeij JT; van Knapen F
    Antimicrob Agents Chemother; 1995 Jun; 39(6):1265-8. PubMed ID: 7574513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of anti-angiogenic tyrosine kinase inhibition on wound healing--the obvious and not so obvious.
    McCarty ME; Ellis LM
    Cancer Biol Ther; 2002; 1(2):127-9. PubMed ID: 12212612
    [No Abstract]   [Full Text] [Related]  

  • 15. Investigation of novel fumagillin analogues as angiogenesis inhibitors.
    Pyun HJ; Fardis M; Tario J; Yang CY; Ruckman J; Henninger D; Jin H; Kim CU
    Bioorg Med Chem Lett; 2004 Jan; 14(1):91-4. PubMed ID: 14684305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel bicyclic oxazolone derivatives as anti-angiogenic agents.
    Perron-Sierra FM; Pierré A; Burbridge M; Guilbaud N
    Bioorg Med Chem Lett; 2002 Jun; 12(11):1463-6. PubMed ID: 12031320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of aminopeptidase activity from three species of microsporidia: Encephalitozoon cuniculi, Encephalitozoon hellem, and Vittaforma corneae.
    Millership JJ; Chappell C; Okhuysen PC; Snowden KF
    J Parasitol; 2002 Oct; 88(5):843-8. PubMed ID: 12435118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of polyoxin D and nikkomycin Z against Encephalitozoon cuniculi.
    Sobottka I; Bartscht K; Schäfer P; Weitzel T; Schottelius J; Kock N; Laufs R
    Parasitol Res; 2002 May; 88(5):451-3. PubMed ID: 12049463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiparasitic activities of novel, orally available fumagillin analogs.
    Arico-Muendel C; Centrella PA; Contonio BD; Morgan BA; O'Donovan G; Paradise CL; Skinner SR; Sluboski B; Svendsen JL; White KF; Debnath A; Gut J; Wilson N; McKerrow JH; DeRisi JL; Rosenthal PJ; Chiang PK
    Bioorg Med Chem Lett; 2009 Sep; 19(17):5128-31. PubMed ID: 19648008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo efficacy of albendazole against Encephalitozoon cuniculi in SCID mice.
    Koudela B; Lom J; Vítovec J; Kucerová Z; Ditrich O; Trávnícek J
    J Eukaryot Microbiol; 1994; 41(5):49S-50S. PubMed ID: 7804252
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.